Kymera Therapeutics (KYMR)
(Real Time Quote from BATS)
$35.20 USD
+0.86 (2.50%)
Updated Apr 23, 2024 09:54 AM ET
3-Hold of 5 3
F Value B Growth D Momentum D VGM
Key Expected Earnings Data
Report Date | Period Ending | Zacks Consensus Estimate | Earnings ESP |
---|---|---|---|
05/02/2024
Time: -- |
3/2024 | $-0.72 | 21.05% |
Earnings Summary
For their last quarter, Kymera Therapeutics (KYMR) reported earnings of -$0.25 per share, beating the Zacks Consensus Estimate of $-0.44 per share. This reflects a positive earnings surprise of 43.18%. Look out for KYMR's next earnings release expected on May 02, 2024. For the next earning release, we expect the company to report earnings of -$0.72 per share, reflecting a year-over-year decrease of 2.86%.
Earnings History
Price & Consensus
Zacks News for KYMR
Kymera Therapeutics, Inc. (KYMR) Expected to Beat Earnings Estimates: Should You Buy?
KYMR: What are Zacks experts saying now?
Zacks Private Portfolio Services